X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-05-16 | REGN | Yancopoulos George | Bd. Co-Chair, Pres, CSO | S - Sale | $972.73 | -50,000 | 1,148,844 | -4% | -$48,636,545 | ||||||
2024-05-15 | REGN | Yancopoulos George | Bd. Co-Chair, Pres, CSO | S - Sale | $975.88 | -50,000 | 1,198,844 | -4% | -$48,793,727 | ||||||
2024-01-02 | REGN | Yancopoulos George | Bd. Co-Chair, Pres, CSO | S - Sale | $900.00 | -16,848 | 1,217,856 | -1% | -$15,163,200 | ||||||
2024-01-02 | REGN | Yancopoulos George | Bd. Co-Chair, Pres, CSO | S - Sale | $900.00 | -16,848 | 1,217,856 | -1% | -$15,163,200 | ||||||
2023-03-23 | REGN | Yancopoulos George | Pres, Chief Scientific | S - Sale | $804.26 | -3,656 | 1,222,370 | 0% | -$2,940,374 | ||||||
2023-02-06 | REGN | Yancopoulos George | Pres, Chief Scientific | S - Sale | $800.08 | -13,189 | 1,226,026 | -1% | -$10,552,255 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |